4.6 Review

Pharmaceutical development, composition and quantitative analysis of phthalocyanine as the photosensitizer for cancer photodynamic therapy

期刊

出版社

ELSEVIER
DOI: 10.1016/j.jpba.2013.05.014

关键词

Photodynamic therapy; Reactive oxygen species; Photosensitizer; Phthalocyanine

资金

  1. National Science Foundation of China [81201709, 81273548, 21101028]
  2. China Postdoctoral Science Foundation [2012M511441]
  3. Science and Technology Foundation of Fujian Province of China [2011J0104]
  4. Science Foundation of Education Department of Fujian Province of China [JK2010003]

向作者/读者索取更多资源

Phthalocyanine (Pc) and its related derivatives are a class of functional materials that are easily activated by the light at a special wavelength. As such photosensitizer, Pc has been applied to photodynamic therapy (PDT), in addition to its broad applications in many fields, for both malignant and benign diseases. One of our long-term research focuses is to develop Pc for cancer therapy. Herein we briefly review mechanisms of action of Pc used for photodynamic therapy, its pharmaceutical development and molecular modification to enhance its drugability and improve its intracellular localization. We also describe the current status of the Pc derivatives under clinical investigation, and analyze the methods used for quantitative analysis of those Pc derivatives. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据